|Articles|August 1, 2006
- Pharmaceutical Executive-08-01-2006
- Volume 0
- Issue 0
Getting Better
Is the golden age of drug development over? Fat chance. Decade-by-decade comparisons show how new medicines improve on old ones. And that's innovation.
Advertisement
Articles in this issue
about 20 years ago
Time Machineabout 20 years ago
States Curb Marketingabout 20 years ago
From the Editor: Take Your Seatabout 20 years ago
Viewpoint: In Your Wordsabout 20 years ago
Quiz Answersabout 20 years ago
Introduction: Pharm Exec at 25about 20 years ago
How Far We've ComeAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report
3
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
4
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
5